O-2545
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by EdChem (talk | contribs) at 10:12, 2 August 2016 (italicise and unit spacing). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Legal status | |
---|---|
Legal status |
|
Identifiers | |
| |
CAS Number | |
ChemSpider |
|
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C26H36N2O2 |
Molar mass | 408.575 g/mol g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
O-2545 is an analgesic cannabinoid derivative created by Organix Inc. for use in scientific research. Unlike most cannabinoids discovered to date, it is water-soluble, which gives it considerable advantages over many related cannabinoids. It has high affinity for both CB1 and CB2 receptors, with Ki values of 1.5 nM at CB1 and 0.32 nM at CB2.[1]
See also
References
- ^ Martin BR, et al. Pharmacological characterization of novel water-soluble cannabinoids. Journal of Pharmacology and Experimental Therapeutics. 2006 Sep;318(3):1230-9. PMID 16757541
This cannabinoid related article is a stub. You can help Wikipedia by expanding it. |
Retrieved from "https://en.wikipedia.org/w/index.php?title=O-2545&oldid=732651367"
Hidden categories:
- Drugs with non-standard legal status
- Articles with changed ChemSpider identifier
- Chem-molar-mass both hardcoded and calculated
- Infobox-drug molecular-weight unexpected-character
- Articles with changed InChI identifier
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugs missing an ATC code
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- All stub articles